Evidence map›Paper›PMID 25234874›Full record

ArticleThe Journal of the Acoustical Society of America2014

Cavitation thresholds of contrast agents in an in vitro human clot model exposed to 120-kHz ultrasound.

Matthew J Gruber, Kenneth B Bader, Christy K Holland

Abstract read
In one paragraph

Article in The Journal of the Acoustical Society of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Characterization of cavitation-radiated acoustic power using diffraction correction.The Journal of the Acoustical Society of America · 2018
    Article
  8. Article
  9. Closed-loop control of targeted ultrasound drug delivery across the blood-brain/tumor barriers in a rat glioma model.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Matthew J GruberBiomedical Engineering Program, University of Cincinnati, Cardiovascular Center 3941, 231 Albert Sabin Way, Cincinnati, Ohio 45267-0586.
Kenneth B BaderDepartment of Internal Medicine, Division of Cardiovascular Health and Diseases, University of Cincinnati, Cardiovascular Center 3941, 231 Albert Sabin Way, Cincinnati, Ohio 45267-0586.
Christy K HollandDepartment of Internal Medicine, Division of Cardiovascular Health and Diseases, University of Cincinnati, Cardiovascular Center 3941, 231 Albert Sabin Way, Cincinnati, Ohio 45267-0586.

Funding

Ultrasound-Assisted Thrombolysis for Stroke TherapyR01NS047603 · NINDS · UNIVERSITY OF CINCINNATI · PI HOLLAND, CHRISTY K. · 2004 to 2018
$7.5M
TARGETED LIPOSOMES FOR ACOUSTIC CARDIOVASCULAR IMAGINGR01HL059586 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 1998 to 2012
$3.2M
Targeted Liposomes for Acoustic Cardiovascular ImagingR56HL059586 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2008 to 2008
$480k
NHLBI NIH HHS HL059586NHLBI NIH HHS R01 HL059586NHLBI NIH HHS R56 HL059586NINDS NIH HHS NS047603NINDS NIH HHS R01 NS047603
6 · The paper itself

Abstract

Ultrasound contrast agents (UCAs) can be employed to nucleate cavitation to achieve desired bioeffects, such as thrombolysis, in therapeutic ultrasound applications. Effective methods of enhancing thrombolysis with ultrasound have been examined at low frequencies (<1 MHz) and low amplitudes (<0.5 MPa). The objective of this study was to determine cavitation thresholds for two UCAs exposed to 120-kHz ultrasound. A commercial ultrasound contrast agent (Definity(®)) and echogenic liposomes were investigated to determine the acoustic pressure threshold for ultraharmonic (UH) and broadband (BB) generation using an in vitro flow model perfused with human plasma. Cavitation emissions were detected using two passive receivers over a narrow frequency bandwidth (540-900 kHz) and a broad frequency bandwidth (0.54-1.74 MHz). UH and BB cavitation thresholds occurred at the same acoustic pressure (0.3 ± 0.1 MPa, peak to peak) and were found to depend on the sensitivity of the cavitation detector but not on the nucleating contrast agent or ultrasound duty cycle.

Indexed as

Contrast MediaFluorocarbonsHumansLipidsLiposomesMechanical ThrombolysisPressureSoundThrombosisUltrasonic TherapyVibrationContrast MediaFluorocarbonsLipidsLiposomesperflutren

Identifiers

PMID25234874
PMCPMC3986017

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.